The effect of apatinib combined with chemotherapy or targeted therapy on non‐small cell lung cancer in vitro and vivo

BACKGROUND: The aim of this study was to investigate the feasibility of using a combination of apatinib in the treatment of non‐small cell lung cancer. Apatinib is a tyrosine kinase inhibitor which selectivelyacts on vascular endothelial growth factor receptor 2 (VEGFR‐2) and has shown good efficacy...

Full description

Saved in:
Bibliographic Details
Published in:Thorac Cancer
Main Authors: Liu, Mingtao, Wang, Xiuxiu, Li, Hui, Xu, Lisheng, Jing, Lijun, Jiang, Peng, Liu, Baoyi, Li, Yu
Format: Artigo
Language:Inglês
Published: John Wiley & Sons Australia, Ltd 2019
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6775003/
https://ncbi.nlm.nih.gov/pubmed/31486270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13162
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items